I N T R O D U C T I O N

In concert with our MISSION to accelerate discoveries of the causes and treatments of age-related memory loss and cognitive decline, to promote brain health through multi-disciplinary collaborations and partnerships, and to train new generations of skilled clinical and translational scientists specializing in age-related memory loss, cognitive decline and the promotion of brain health, along with our VISION to become a leading center for clinical and translational research into the causes, treatments and prevention of age-related cognitive disorders and promotion of brain health, the University of Miami Evelyn F. McKnight Brain Institute has strived to blossom and expand our reach. In this year’s report, we describe how we propelled our mission and vision forward.

Our Evelyn F McKnight Brain Institute (EMBI) continued to flourish in this post-pandemic environment, and we are so excited to share our achievements Dr. Sacco was selected by the American Heart Association (AHA) as a distinguished scientist and Dr. Rundek was elected to the Academy of Science, Engineering and Medicine of Florida (ASCMF). Dr. Galvin was appointed Chief of the Cognitive Division and his precision aging-like personalized medicine model for brain health became actualized with the opening of the Comprehensive Center for Brain Health (CCBH) Dr. Ramos started his large, multi-centered R01 research on sleep and neurocognitive aging Dr. Camargo completed all data collection for his McKnight Brain Foundation and AAN awarded research project entitled Reducing the Effects of Aging on Cognition with Therapeutic Intervention of an Oral Nutrient: A Pilot Trial (REACTION). Our EMBI was well represented at the 2022 Alzheimer’s Association International Conference (AAIC) in San Diego, Ca. We actively participated in the 13th McKnight Annual Inter-Institutional meeting held at the University of Arizona in Tucson Furthermore, we published impactful papers in the field of brain and cognitive aging research Drs. Rundek and Levin successfully initiated the NIA U19 Precision Aging Network (PAN) research project at the University of Miami. Dr. Sun expanded our educational collaborative programming and enhanced our specialization of community outreach and partnering. We continued to mentor numerous trainees who are successfully obtaining NIH K and K-like awards. Dr. Rundek submitted four NIH training grants to continue to support training programs and reach the next generation of clinician-scientists in cognition and aging She also co-led the resubmission of the University of Miami Clinical Translational Science Institute to NCATS as Director of the K12 Mentored Research Career Development Program in Clinical and Translational Science. Our commitment to broadening our reach within the community we serve via website and social media continued to be successful.

Our EMBI scientific, programmatic, training, education and outreach achievements and our most important achievements are described in this section, Institute FY22 at a Glance.